Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.

Pharmaceutical

Stada Group

Peter Goldschmidt

Patrick Genestin

Christos Gallis

Stéphane Jacqmin

Boris Doebler

Simone Berger

Christoph Dengler

Bryan Kim

Miguel Pagan Fernandez

Stephan Eder

Volker Sydow

Frank Staud

Yann Brun

The Quality Assurance and Compliance team at Stada Group ensures that all pharmaceutical products meet rigorous quality standards and regulatory requirements. This team conducts audits, manages quality investigations, and oversees compliance with Good Manufacturing Practices (GMP) across global operations. They work closely with suppliers and internal stakeholders to optimize processes and mitigate risks, ensuring the safety and efficacy of both generics and branded products.

Quality Assurance and Compliance

Sales and Marketing

Leadership Team

Research and Development

��

Quality Assurance and Compliance

About

Team members

Other teams at Stada Group

Sales and Marketing

Leadership Team

Research and Development

��������

Quality Assurance and Compliance

About

Team members

Other teams at Stada Group

Sales and Marketing

Leadership Team

Research and Development

��